Please login to the form below

Not currently logged in
Email:
Password:

Merial

This page shows the latest Merial news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim calls for "strong and united" Europe

Boehringer Ingelheim calls for

2016 was a disruptive year for Boehringer Ingelheim, punctuated by the sale of its consumer health and US generics business and the absorption of Sanofi's animal health unit Merial, which

Latest news

More from news
Approximately 2 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    animal health business (Merial) for Boehringer Ingelheim's consumer healthcare business.

  • Deal Watch October 2016 Deal Watch October 2016

    In June, Boehringer Ingelheim agreed to takeover Sanofi's veterinary business, Merial, in return for handing over its OTC business. ... pet vaccines business and Fort Dodge manufacturing site is a required step toward the acquisition of Merial by

  • The human perspective The human perspective

    The latter deal will see Boehringer hand its consumer health interests to Sanofi in return for the French pharma firm's animal health arm Merial.

  • Deal Watch December 2015 Deal Watch December 2015

    As the enterprise value of Sanofi's animal business, Merial, was estimated at 11.4bn versus 6.7bn for Boehringer's consumer health business, Boehringer is required to pay 4.7bn (

  • Pharma deals during December 2012 Pharma deals during December 2012

    In a similar move to expand global presence, Sanofi's animal health company, Merial, has acquired the Indian veterinary business Dosch for an undisclosed amount.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Executive changes at Sanofi Executive changes at Sanofi

    Carsten Hellmann (pictured left) joins Sanofi from food ingredient company Chr Hansen and takes over from Jose Barella as executive VP for Sanofi's animal health division Merial. ... He now takes control of a company with annual revenues of more than 2bn,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics